"UPMC Hillman Cancer Center - Erie (Radiation Oncology) is a Cancer treatment center located in Erie, Pa. Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Hillman Cancer Center Erie conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 24 clinical trials were completed, i.e. on average, 52.2% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 14 clinical trials were completed. i.e. 56% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Hillman Cancer Center Erie" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored, "NRG Oncology" with 6 trials sponsored and "NSABP Foundation Inc" with 6 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Hillman Cancer Center Erie" #1 collaborator was "National Cancer Institute (NCI)" with 31 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Canadian Cancer Trials Group" with 4 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Hillman Cancer Center Erie" are "Breast Cancer" (7 trials), "Stage IIIB Lung Cancer AJCC v8" (5 trials), "Recurrent Lung Non-Small Cell Carcinoma" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials) and "Stage IIIA Lung Cancer AJCC v8" (4 trials). Many other conditions were trialed in "UPMC Hillman Cancer Center Erie" in a lesser frequency.

Most popular intervention types in "UPMC Hillman Cancer Center Erie" are "Drug" (59 trials), "Other" (37 trials), "Radiation" (28 trials), "Biological" (27 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (16 trials), "Laboratory Biomarker Analysis" (15 trials), "Paclitaxel" (14 trials), "Cisplatin" (13 trials) and "Carboplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Hillman Cancer Center Erie" are 54 trials for "All" genders, 14 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC Hillman Cancer Center Erie". undefined are not yet recruiting, 26 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in UPMC Hillman Cancer Center Erie, 2 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Hillman Cancer Center Erie, 3 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".